2019 International Congress

Tuesday, September 24, 2019

1:45pm-3:15pm

Osteopathic Manipulative Medicine to Improve Balance and Quality of Life in Parkinson Disease

S. Yao, J. Docherty, J. Mancini, A. Leder, J. Difrancisco-Donoghue (Old Westbury, NY, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Overnight unilateral withdrawal of VIM-DBS to identify reversibility of gait disturbances

D. Kroneberg, D. Kübler, B. Al-Fatly, AC. Meyer, GH. Schneider, A. Kühn (Berlin, Germany)

Tremor  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Pain assessment and pain management study in patients with Parkinson’s disease in Uzbekistan

A. Umarov, D. Tolibov (Tashkent, Uzbekistan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Pain in patients with multiple system atrophy: a pain-related evoked potential study

M. Takeda, F. Okada, H. Tachibana, S. Kasama, H. Yoshikawa (Nishinomiya, Japan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinson Disease Clinical Subtypes Predict Dementia and Mortality Risk

P. Myers, M. Campbell, A. Weigand, N. Cairns, J. Jackson, C. Lessov-Schlaggar, J. Perlmutter (St. Louis, MO, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

PARKINSON DISEASE HAMPERS PARTICIPATION IN THE CIVIC RESPONSIBILITY OF VOTING: a study of barriers to expression of a fundamental human right

O. Oguntunde, O. Ojo, O. Agabi, M. Rizig, N. Okubadejo (Lagos, Nigeria)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinson’s Disease Presentation in Calabar, Nigeria

S. Oparah, U. Williams, J. Mwankon (Calabar, Nigeria)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinson’s disease-associated mutations of PLA2G6 alters the membrane dynamics and α-synuclein stability

ａ. Mori, T. Hatano, T. Inoshita, K. Shiba-Fukushima, T. Koinuma, C. Yamashita, A. Okuzumi, Y. Imai, ｎ. Hattori (Tokyo, Japan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinson’s disease and melanoma: a serie of 33 patients

J. Doridam, M. Nader, A. Melin, MF. Avril, E. Maubec, B. Degos (Paris, France)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinson’s disease polygenic risk score is not associated with impulse control disorders: a longitudinal study

J. Ihle, F. Artaud, S. Bekadar, G. Magnone, H. Bertrand, S. Sambin, LL. Mariani, C. Scherzer, A. Elbaz, JC. Cornol (Paris, France)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3